GSK Bio Meningococcal Vaccine 134612
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK Bio Meningococcal Vaccine 134612, covering 2018-06-04 to 2018-06-04. Get the full timeline:
Most recent: Clinical Trial Update: Study in Children to Evaluate Non-Inferiority and Persistence up to 5 Years of GSK Bio Meningococcal Vaccine 134612 [Phase 2]